New York State Common Retirement Fund’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-9,964
| Closed | -$201K | – | 3260 |
|
|
2026
Q1 | $201K | Hold |
9,964
| – | – | ﹤0.01% | 2235 |
|
|
2025
Q4 | $161K | Hold |
9,964
| – | – | ﹤0.01% | 2377 |
|
|
2025
Q3 | $121K | Hold |
9,964
| – | – | ﹤0.01% | 2530 |
|
|
2025
Q2 | $113K | Hold |
9,964
| – | – | ﹤0.01% | 2510 |
|
|
2025
Q1 | $115K | Hold |
9,964
| – | – | ﹤0.01% | 2455 |
|
|
2024
Q4 | $84.4K | Hold |
9,964
| – | – | ﹤0.01% | 2662 |
|
|
2024
Q3 | $115K | Sell |
9,964
-28,769
| -74% | -$362K | ﹤0.01% | 2520 |
|
|
2024
Q2 | $456K | Buy |
38,733
+28
| +0.1% | +$327 | ﹤0.01% | 2077 |
|
|
2024
Q1 | $459K | Buy |
38,705
+28,791
| +290% | +$384K | ﹤0.01% | 2117 |
|
|
2023
Q4 | $121K | Sell |
9,914
-45
| -0.5% | -$409 | ﹤0.01% | 2669 |
|
|
2023
Q3 | $95.9K | Buy |
9,959
+9,451
| +1,860% | +$96.6K | ﹤0.01% | 2744 |
|
|
2023
Q2 | $4.57K | Sell |
508
-10,100
| -95% | -$93.1K | ﹤0.01% | 3278 |
|
|
2023
Q1 | $83.4K | Sell |
10,608
-6,179
| -37% | -$46.1K | ﹤0.01% | 2863 |
|
|
2022
Q4 | $113K | Sell |
16,787
-32
| -0.2% | -$171 | ﹤0.01% | 2923 |
|
|
2022
Q3 | $244K | Buy |
16,819
+64
| +0.4% | +$895 | ﹤0.01% | 2677 |
|
|
2022
Q2 | $165K | Sell |
16,755
-55
| -0.3% | -$607 | ﹤0.01% | 2879 |
|
|
2022
Q1 | $248K | Buy |
16,810
+4,147
| +33% | +$59.6K | ﹤0.01% | 2734 |
|
|
2021
Q4 | $168K | Sell |
12,663
-7,284
| -37% | -$116K | ﹤0.01% | 2931 |
|
|
2021
Q3 | $348K | Sell |
19,947
-21,149
| -51% | -$429K | ﹤0.01% | 2661 |
|
|
2021
Q2 | $985K | Buy |
41,096
+7,437
| +22% | +$195K | ﹤0.01% | 2250 |
|
|
2021
Q1 | $865K | Buy |
33,659
+21,659
| +180% | +$569K | ﹤0.01% | 2183 |
|
|
2020
Q4 | $228K | Hold |
12,000
| – | – | ﹤0.01% | 2702 |
|
|
2020
Q3 | $151K | Hold |
12,000
| – | – | ﹤0.01% | 2767 |
|
|
2020
Q2 | $145K | Hold |
12,000
| – | – | ﹤0.01% | 2790 |
|
|
2020
Q1 | $92K | Hold |
12,000
| – | – | ﹤0.01% | 2802 |
|
|
2019
Q4 | $214K | Hold |
12,000
| – | – | ﹤0.01% | 2715 |
|
|
2019
Q3 | $139K | Hold |
12,000
| – | – | ﹤0.01% | 2929 |
|
|
2019
Q2 | $266K | Buy |
+12,000
| New | +$281K | ﹤0.01% | 2682 |
|
|
2016
Q2 | – | Sell |
-807
| Closed | -$7K | – | 3200 |
|
|
2016
Q1 | $7K | Hold |
807
| – | – | ﹤0.01% | 3134 |
|
|
2015
Q4 | $41K | Hold |
807
| – | – | ﹤0.01% | 3125 |
|
|
2015
Q3 | $40K | Buy |
807
+402
| +99% | +$34.3K | ﹤0.01% | 3130 |
|
|
2015
Q2 | $41K | Buy |
+405
| New | +$40.2K | ﹤0.01% | 3226 |
|
Other funds holding KALV
New York State Common Retirement Fund's KALV Position: Q2 2026 in Review
New York State Common Retirement Fund sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 9,964 shares — an estimated $201K sold.
New York State Common Retirement Fund first reported a position in KALV in Q2 2015 and held it in 32 quarters. The position peaked at $985K in Q2 2021. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.
- New York State Common Retirement Fund reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- New York State Common Retirement Fund sold 9,964 KalVista Pharmaceuticals shares in Q2 2026, an estimated $201K.
- New York State Common Retirement Fund first reported a position in KalVista Pharmaceuticals in Q2 2015 and held it in 32 quarters.
- New York State Common Retirement Fund's KalVista Pharmaceuticals position peaked at $985K in Q2 2021.
- 1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.